- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01573013
Iron Fortification Trail Using NaFeEDTA in Iron Deficient Lead-exposed Children
Interactions of Lead Intoxication and Iron Deficiency in Morocco: The Effects of Iron Fortification With and Without NaEDTA on Lead Burden, Iron Status and Cognition in Children
In a cross-sectional study allotted by the ethical committee of the ETH Zurich, we are investigating the extent of anemia, iron deficiency and lead intoxication in young children. For this purpose an assessment of body lead burden and iron status was conducted in a cohort of individuals residing in areas of presumed high lead exposure. Associations between lead burden and iron status will be investigated in the near future (current status of the study).
In a follow-on intervention study, the effect of iron fortification with and without NaEDTA on blood lead levels in lead-exposed children will be evaluated; and the relative impact of these two strategies on child growth, motor and cognitive test performance will be compared.
This study will investigate the potential use of iron fortification to not only combat anemia but also reduce body lead burden in lead-exposed populations; it specifically investigates whether iron fortification with NaFeEDTA could have additional beneficial effects to iron alone.
Study Overview
Status
Conditions
Detailed Description
Introduction Coexisting chronic lead poisoning and iron deficiency anemia (IDA) are common in urban areas in developing regions, particularly in young children. In urban Morocco, anemia affects more than 1/3rd of schoolchildren and lead exposure is high. Lead poisoning and IDA both impair cognitive development and educability and may therefore have substantial health, social and economic costs on developing countries.
Iron status alters susceptibility to gastrointestinal lead exposure; absorption of lead is sharply increased in children with IDA. IDA upregulates the divalent metal transporter trans-port protein (DMT-1) and increases lead absorption. Thus, iron fortification to reduce IDA may also reduce lead absorption and be an effective strategy to accompany environmental lead abatement. The optimal iron compound for wheat flour is currently debated, and although elemental iron compounds are commonly used, they may be only poorly absorbed in the face of inhibitory compounds found in wheat flour.
A form of chelated iron, NaFeEDTA, is a promising iron fortificant that is recommended for wheat flour fortification. It is also a lead chelator. It may be superior to other iron fortificants in its ability to reduce body lead burden, due to:
- its iron is highly bioavailable in the face of dietary inhibitors (such as phytic acid in wheat flour); and
- potentially, its ability to chelate lead in the gut and bloodstream. Thus, it may be a good choice for fortification of wheat flour in Morocco, particularly in urban areas, to both reduce IDA and lower body lead.
Study aims and objectives:
- Assessment of body lead burden and iron status in a cohort of individuals residing in areas of presumed high lead exposure. Investigation of associations between lead burden and iron status.
- Comparison of effect of iron fortification with and without NaEDTA on body lead and iron status in lead-exposed children; and the relative impact on cognition.
Study hypotheses:
The prevalence of iron deficiency and elevated blood lead will be high in children in this region.
2) Body lead burden, as assessed by blood lead levels and urinary lead and delta-aminolevulinic acid (ALA), will be higher in individuals with poorer iron status.
3) Poor iron status will be associated with low intakes of bioavailable iron. 4) Greater severity of iron deficiency and/or higher body lead in children will predict poorer performance on cognitive and motor tests, and these conditions will interact to predict poorer performance.
Study design:
Our studies will be carried out in one of the four sub-economic areas, that were previously used in the baseline assessment in and near Marrakesh, Morocco (exact site still needs to be determined according to extend of lead contamination on the level of human population). Body lead burden and iron status will be determined, and associations between these examined using a cross-sectional design. For this purpose, blood and urine samples will be collected from two groups (preschool and school-aged children), residing in an area of high lead exposure.
Study design:
An 8-month intervention study in iron deficient, lead-exposed school children (n=500) will be designed to investigate whether iron fortification to reduce IDA may also reduce lead absorption and be an effective strategy to accompany environmental lead abatement.
For this purpose these children will be divided into four groups to receive a daily fortified baked snack containing either: 1) 66.4 mg NaFeEDTA ; 2) 52.2 mg Na2EDTA dehydrate; 3) 27.1 mg FeSO4 ; or 4) no fortificants.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zurich, Switzerland, 8092
- Swiss federal institute of Technology (ETH)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- school and preschool children living in a lead-exposed environment with a high prevalence of iron deficiency
Exclusion Criteria:
- chronic or severe illnesses
- history of bleeding disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: NaFeEDTA treatment, biscuit
Group receives 10 mg of Fe in form of NaFeEDTA per day.
wheat flour based biscuit
|
10 mg of iron per day for 8 months, either in the form of NaFeEDTA
10 mg of iron per day for 8 months, in the form of FeSo4
EDTA fortified biscuit on a daily basis for 8 months
control biscuit on a daily basis for 8 months
|
Active Comparator: EDTA treatment, biscuit
Group receives Na2EDTA enriched biscuit
|
10 mg of iron per day for 8 months, either in the form of NaFeEDTA
10 mg of iron per day for 8 months, in the form of FeSo4
EDTA fortified biscuit on a daily basis for 8 months
control biscuit on a daily basis for 8 months
|
Active Comparator: FeSO4 treatment, biscuit
Group receives 10 mg of iron as FeSo4 per day for 8 months
|
10 mg of iron per day for 8 months, either in the form of NaFeEDTA
10 mg of iron per day for 8 months, in the form of FeSo4
EDTA fortified biscuit on a daily basis for 8 months
control biscuit on a daily basis for 8 months
|
Placebo Comparator: control treatment, biscuit
group receives a biscuit without additional iron
|
10 mg of iron per day for 8 months, either in the form of NaFeEDTA
10 mg of iron per day for 8 months, in the form of FeSo4
EDTA fortified biscuit on a daily basis for 8 months
control biscuit on a daily basis for 8 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
body lead burden
Time Frame: 8 months
|
changes in blood lead levels over time of the intervention
|
8 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Iron status
Time Frame: 8 months
|
changes in iron status (SF,Hb, TfR) before and after intervention
|
8 months
|
cognitive development
Time Frame: 8 months
|
changes in cognitive development (using the K ABC II) before and after intervention
|
8 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Michael B Zimmermann, Prof. Dr. med, Swiss federal institute of Technology (ETH)
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IZ70Z0_123902 (Other Grant/Funding Number: The Swiss National Science Foundation (SNSF)/Project Nr. IZ70Z0_123902)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron Deficiency
-
Pennington Biomedical Research CenterRecruitingIron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia TreatmentUnited States
-
King's CollegeCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)United States
-
Children's Hospital Los AngelesNot yet recruitingAnemia | Iron Deficiency Anemia | Anemia, Iron Deficiency | IDA - Iron Deficiency AnemiaUnited States
-
Swiss Federal Institute of TechnologyUnited States Agency for International Development (USAID); Quadram Institute... and other collaboratorsCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)Peru
-
Arrowhead Regional Medical CenterRecruitingIron Deficiency Anemia of PregnancyUnited States
-
Iowa State UniversityCompletedIron-deficiency | Bioavailability | Anemia, Iron Deficiency | Absorption; Iron | Serum IronUnited States
-
Société des Produits Nestlé (SPN)CompletedIron-deficiency | Anemia | Iron Deficiency AnemiaPhilippines
-
Swiss Federal Institute of TechnologyUniversity of MalawiCompletedIron-deficiency | Iron Deficiency AnemiaMalawi, Switzerland
-
Johann Wolfgang Goethe University HospitalLudwig-Maximilians - University of MunichCompletedNon-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IXIron-deficiency | Anemia | Iron Deficiency AnemiaGermany
-
Kansas State UniversityUnited States Department of Agriculture Foreign Agricultural Service; American...CompletedIron-deficiency | Iron Deficiency AnemiaUnited States
Clinical Trials on iron fortified biscuits
-
Prof. Michael B. ZimmermannUnknown
-
Hospices Civils de LyonCompletedCardiometabolic Risk | Abdominal ObesityFrance
-
Carol HenryMarywood University; Brac; Nutrition InternationalUnknownIron-deficiency | Anemia, Iron-Deficiency | Cognitive PerformanceBangladesh
-
Pennington Biomedical Research CenterThe Wright Group in Crowley, LACompletedIron Deficiency AnemiaUnited States
-
University of ManitobaCompletedIntestinal Inflammation | Generation of Reactive Oxygen SpeciesCanada
-
NestléFood and Nutrition Research Institute, Philippines; ETH Zurich (Switzerland)Completed
-
Umeå UniversityUniversity of California, Davis; Swiss Federal Institute of TechnologyCompletedInfant | Dietary Supplements | Food, FortifiedSweden
-
Unilever R&DObafemi Awolowo UniversityCompletedAssessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian WomenIron Deficiency AnemiaNigeria
-
Federal University of Minas GeraisFundação de Amparo à Pesquisa do estado de Minas GeraisCompletedAnemia | Iron Deficiency AnemiaBrazil
-
National University of SingaporeMinistry of Education, SingaporeActive, not recruitingDiabetes | Metabolic Syndrome | Diet ModificationSingapore